DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
clinicaltrials.gov.
NCT03701334, A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer (NATALEE). NIH U.S. National Library of Medicine, 2018.
Accessed November 07, 2020 at:
https://clinicaltrials.gov/ct2/show/NCT03701334
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.